Looking ahead to what the medtech industry can expect in 2019, I see a continuation of some of the greatest accomplishments of 2018, such as ongoing collaboration with regulatory bodies and real-world evidence driving more reimbursement discussions, as well as the brave new world of digital health continuing to buoy how our industry can help patients.
Among the bright spots and reasons for hope, my predictions for the coming year unfortunately involve a number of threats that are gathering on the horizon. If the recent investigative report "Implant Files"—launched by the International Consortium of Investigative Journalists—is any indication, it's fair to say that there are a number of challenges facing the medtech sector in the coming year.
I wrote about my five predictions for medtech in 2019 for In Vivo, and while I tried to keep it light, as an industry, it pays to be diligent in tracking and preparing to weather such storms.
BLOG POST: Ushering in 2019: Medtech's Year to Come
BLOG POST: What to Expect in Medtech for 2018